Auxly Cannabis Group Inc., - CEO, Hugo Alves
CEO, Hugo Alves
Source: BNN Bloomberg
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Auxly Cannabis Group (TSXV:XLY) has entered into a supply agreement with its strategic partner, Delta 9 Cannabis
  • Auxly will now supply cannabis oils, extracts and edibles to Delta 9’s retail stores
  • Delta 9 currently operates four cannabis retail stores in Manitoba and is planning to expand further
  • Auxly Cannabis Group (XLY) is down 3.70 per cent, with shares currently trading for $0.52

Auxly Cannabis (TSXV:XLY) has entered into a supply agreement with its strategic retail partner, Delta 9 Cannabis. 

According to the agreement, Auxly will provide Delta 9 with a range of cannabis products, which Delta 9 will sell in its stores across Manitoba.

Since October 2017, Delta 9 stores have been performing well in Canada. In its first year of legal cannabis sales, Delta 9 reported over C$14 million in revenue, and more than 250,000 transactions.

Delta 9 currently has four cannabis retail stores in Manitoba but plans to expand the chain.

Hugo Alves, CEO of Auxly, is excited about the new supply agreement.

“We are thrilled that consumers will be able to purchase our suite of cannabis products including oils, chocolates, chewables, and vape products.

“Delta 9 was one of our first strategic partners, and we are so excited to reaffirm our partnership and joint commitment,” he said.

Auxly Cannabis Group (XLY) was down 3.70 per cent, with shares trading for $0.52 at 2:22pm EST.

More From The Market Herald

" The Market Herald’s Weekly Cannabis Report – June 2, 2023

Avicanna Inc. (TSX:AVCN) has signed a definitive agreement to acquire Shoppers Drug Mart’s medical cannabis business.

" Shoppers Drug Mart exits medical cannabis business

Avicanna has signed a definitive agreement to acquire Shoppers Drug Mart’s medical cannabis business.

" The Market Herald’s Weekly Cannabis Report – May 26, 2023

Tilray Brands Inc. (TSX:TLRY) has received authorization from Italy’s Ministry of Health to distribute three new medical cannabis compounds.